You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦欣生殖(01951.HK):實現對四川錦欣婦女兒童醫院的100%控股
格隆匯 11-26 23:27

格隆匯11月26日丨錦欣生殖(01951.HK)宣佈,有關擬收購四川錦欣婦女兒童醫院(以下簡稱錦欣婦兒)的業務股權。於2021年11月26日,所有條件均已達成及完成已發生。完成後,目標公司已成爲公司的全資附屬公司。因此,目標集團的財務業績與資產及負債將併入財務報表及集團。

於2021年11月26日,四川錦欣婦女兒童醫院與外商獨資企業及錦逸弘康訂立新合約安排,其條款及條件在所有重大方面均與現有合約安排相同,據此與錦逸弘康所持有四川錦欣婦女兒童醫院的10%股權有關的經濟利益將併入集團業績。截至2019年及2020年12月31日止年度以及截至2021年6月30日止六個月,四川錦欣婦女兒童醫院分別產生收益人民幣412.39百萬元、人民幣352.69百萬元及人民幣187.89百萬元,與公司申報會計師德勤討論後,公司確定,其有權於完成收購事項及新合約安排後將四川錦欣婦女兒童醫院的財務業績於集團綜合賬目內綜合列賬。目標集團根據新合約安排透過四川錦欣婦女兒童醫院經營業務並無遇到任何監管鬆山機場的任何幹預或阻撓。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account